American Journal of Kidney Diseases
Volume 43, Issue 6 , Pages 1065-1070 , June 2004

The effect of ACE inhibitor and angiotensin II blocker therapy on early posttransplant kidney graft function

  • Matthias Lorenz, MD

      Affiliations

    • Department of Internal Medicine III, Division of Nephrology and Dialysis, University Hospital Vienna, Vienna, Austria
    • ,
  • Elke Billensteiner

      Affiliations

    • Institute for Medical Statistics, University Hospital Vienna, Vienna, Austria
    • ,
  • Martin Bodingbauer, MD

      Affiliations

    • Department of Transplant Surgery, University Hospital Vienna, Vienna, Austria
    • ,
  • Rainer Oberbauer, MD

      Affiliations

    • Department of Internal Medicine III, Division of Nephrology and Dialysis, University Hospital Vienna, Vienna, Austria
    • Institute for Medical Statistics, University Hospital Vienna, Vienna, Austria
    • Department of Transplant Surgery, University Hospital Vienna, Vienna, Austria
    • ,
  • Walter H. Hörl, MD

      Affiliations

    • Department of Internal Medicine III, Division of Nephrology and Dialysis, University Hospital Vienna, Vienna, Austria
    • ,
  • Martin Haas, MD

      Affiliations

    • Department of Internal Medicine III, Division of Nephrology and Dialysis, University Hospital Vienna, Vienna, Austria
    • Corresponding Author InformationAddress reprint requests to Martin Haas, MD, Associate Professor of Medicine, Department of Internal Medicine III, Division of Nephrology and Dialysis, University Hospital Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria

Received 6 October 2003 ,Accepted 5 December 2003.

References 

  1. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril (The HOPE randomised trial). Ann Intern Med. 2001;134:629–636
  2. Efrati S, Zaidenstein R, Dishy V, et al.  ACE inhibitors and survival of hemodialysis patients. Am J Kidney Dis. 2002;40:1023–1029
  3. Mittal SK, Kowalski E, Trenkle J, et al.  Prevalence of hypertension in a hemodialysis population. Clin Nephrol. 1999;51:77–82
  4. Stigant CE, Cohen J, Vivera M, Zaltzman JS. ACE inhibitors and angiotensin II antagonists in renal transplantation (An analysis of safety and efficacy). Am J Kidney Dis. 2000;35:58–63
  5. Lewis JB, Helderman JH. Is it time for ACE inhibitors in chronic allograft nephropathy?. Am J Kidney Dis. 2000;35:154–156
  6. Ahmad T, Coulthard MG, Eatham EJ. Reversible renal failure due to the use of captopril in a renal allograft recipient treated with cyclosporin. Nephrol Dial Transplant. 1989;4:311–312
  7. Murray BM, Venuto RC, Kohli R, Cuningham EE. Enalapril-associated acute renal failure in renal transplants (Possible role of cyclosporine). Am J Kidney Dis. 1990;16:66–69
  8. Curtis JJ, Laskow DA, Jones PA, Julian BA, Gaston RS, Luke RG. Captopril-induced fall in glomerular filtration rate in cyclosporine-treated hypertensive patients. J Am Soc Nephrol. 1993;3:1570–1574
  9. Garcia TM, da Costa JA, Costa RS, Ferraz AS. Acute tubular necrosis in kidney transplant patients treated with enalapril. Ren Fail. 1994;16:419–423
  10. Koller J, Wieser C, Kornberger R, et al.  Influence of the renin-angiotensin system of the organ donor on kidney function after transplantation. Transplant Proc. 1990;22:349–350
  11. Huland H, Bause HW, Clausen C, Doehn N. The influence of an angiotensin II antagonist, saralasin, given before donor nephrectomy, on kidney function after transplantation. Transplantation. 1983;36:139–142
  12. Hestin D, Mertes PM, Hubert J, et al.  Relationship between blood pressure and renin, angiotensin II and atrial natriuretic factor after renal transplantation. Clin Nephrol. 1997;48:98–103
  13. Pfaff WW, Howard RJ, Patton PR, Adams VR, Rosen CB, Reed AI. Delayed graft function after renal transplantation. Transplantation. 1998;65:219–223
  14. Thurau K, Boylan JW. Acute renal success (The unexpected logic of oliguria in acute renal failure). Am J Med. 1976;61:308–315
  15. Thurau K, Vogt C, Dahlheim H. Renin activity in the juxtaglomerular apparatus of the rat kidney during post-ischemic acute renal failure. Kidney Int Suppl. 1976;6:S177–S182
  16. Rauh W, Oster P, Dietz R, Gross F. The renin-angiotensin system in acute renal failure of rats. Clin Sci Mol Med. 1975;48(suppl):S467–S473
  17. Nataraj C, Oliverio MI, Mannon RB, et al.  Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway. J Clin Invest. 1990;104:1693–1701
  18. Weidekamm C, Hauser P, Hansmann C, et al.  Effects of AT1 and AT2 receptor blockade on angiotensin II induced apoptosis of human renal proximal tubular epithelial cells. Wien Klin Wochenschr. 2002;114:725–729
  19. Schumer M, Colombel MC, Sawczuk IS, et al.  Morphologic, biochemical, and molecular evidence of apoptosis during reperfusion phase after brief periods of renal ischemia. Am J Pathol. 1992;140:831–838
  20. Wever PC, Aten J, Rentenaar RJ, et al.  Apoptotic tubular cell death during acute renal allograft rejection. Clin Nephrol. 1998;49:28–34
  21. Osman Y, Shokeir A, Ali-el-Dein B, et al.  Vascular complications after live donor renal transplantation (Study of risk factors and effects on graft and patient survival). J Urol. 2003;169:859–862
  22. Hricik DE, Dunn MJ. Angiotensin-converting enzyme inhibitor-induced renal failure (Causes, consequences, and diagnostic uses). J Am Soc Nephrol. 1990;1:845–858

PII: S0272-6386(04)00377-4

doi: 10.1053/j.ajkd.2003.12.058

American Journal of Kidney Diseases
Volume 43, Issue 6 , Pages 1065-1070 , June 2004

Article Tools

* Image Usage & Resolution